Literature DB >> 9205677

Damage occurs early in systemic vasculitis and is an index of outcome.

A R Exley1, D M Carruthers, R A Luqmani, G D Kitas, C Gordon, B A Janssen, C O Savage, P A Bacon.   

Abstract

Because death after acute systemic vasculitis is now uncommon, alternative measures of outcome are required. A significant component of patient morbidity is disease-related damage, which can be quantified by the Vasculitis Damage Index (64 items in 11 organ-based systems). We investigated serially the time-course of damage in 120 patients with systemic vasculitis, to determine the earliest indicators of outcome. High damage scores at 2 years after presentation were characteristic of fatal disease (OR 8.1-12.4). Significant damage occurred within 6 months of presentation, and was a feature of fatal disease. More damage occurred after presentation than after relapse. Lung and multi-system damage were early indicators of poor outcome in severe non-fatal disease. Damage occurs early in systemic vasculitis, and is an indicator of poor outcome. This novel observation, together with evidence of persistent subclinical disease activity and the high frequency of relapse, suggests a need for new treatment strategies. Analogy with the management of acute leukaemia suggests a strategy of early diagnosis and intensive induction of remission, with early escalation of treatment for resistant disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9205677     DOI: 10.1093/qjmed/90.6.391

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  16 in total

Review 1.  Pathogenesis and treatment of ANCA-associated systemic vasculitis.

Authors:  A D Salama
Journal:  J R Soc Med       Date:  1999-09       Impact factor: 5.344

Review 2.  Combination therapy in autoimmune disease: vasculitis.

Authors:  D Carruthers; P Bacon
Journal:  Springer Semin Immunopathol       Date:  2001

3.  Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index.

Authors:  Ravi Suppiah; Oliver Flossman; Chetan Mukhtyar; Federico Alberici; Bo Baslund; Denise Brown; Nadeem Hasan; Julia Holle; Zdenka Hruskova; David Jayne; Andrew Judge; Mark A Little; Peter A Merkel; Alessandra Palmisano; Philip Seo; Coen Stegeman; Vladimir Tesar; Augusto Vaglio; Kerstin Westman; Raashid Luqmani
Journal:  Ann Rheum Dis       Date:  2010-08-24       Impact factor: 19.103

Review 4.  Development of comprehensive disease assessment in systemic vasculitis.

Authors:  Oliver Flossmann; Paul Bacon; Kirsten de Groot; David Jayne; Niels Rasmussen; Philip Seo; Kerstin Westman; Raashid Luqmani
Journal:  Ann Rheum Dis       Date:  2006-05-25       Impact factor: 19.103

5.  Long-term damage to the ENT system in Wegener's granulomatosis.

Authors:  Marcos Martinez Del Pero; Michael Walsh; Raashid Luqmani; Oliver Flossmann; Chetan Mukhtyar; Piyush Jani; Niels Rasmussen; David Jayne
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-18       Impact factor: 2.503

Review 6.  Cutting edge issues in the Churg-Strauss syndrome.

Authors:  Wojciech Szczeklik; Bogdan Jakieła; Dariusz Adamek; Jacek Musiał
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

7.  Evaluation of damage in giant cell arteritis.

Authors:  Tanaz A Kermani; Antoine G Sreih; David Cuthbertson; Simon Carette; Gary S Hoffman; Nader A Khalidi; Curry L Koening; Carol A Langford; Carol A McAlear; Paul A Monach; Larry Moreland; Christian Pagnoux; Philip Seo; Kenneth J Warrington; Steven R Ytterberg; Peter A Merkel
Journal:  Rheumatology (Oxford)       Date:  2018-02-01       Impact factor: 7.580

Review 8.  Damage assessment in ANCA-associated vasculitis.

Authors:  Kuljeet Bhamra; Raashid Luqmani
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 9.  An approach to the diagnosis and management of systemic vasculitis.

Authors:  A Miller; M Chan; A Wiik; S A Misbah; R A Luqmani
Journal:  Clin Exp Immunol       Date:  2010-01-12       Impact factor: 4.330

10.  Damage assessment in systemic vasculitis.

Authors:  Luis H Silveira
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.